CTOs on the Move

Dyax Corp.

www.dyax.com

 
Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million
  • www.dyax.com
  • 300 Technology Sq
    Cambridge, MA USA 02139-3515
  • Phone: 617.225.2500

Executives

Name Title Contact Details

Similar Companies

OmniSonics Medical Technologies

At OmniSonics, we are a team of highly dedicated people focused on building technology that will allow physicians to improve the quality of life for patients suffering from vascular diseases - such as deep vein thrombosis (DVT) and peripheral arterial

Nebraska Methodist Health System

Methodist Health System, 3 hospitals, 21 clinic locations, a nursing and allied health college, in Omaha, NE

Juniper Communities

Juniper Communities was founded in 1988 and operates 18 long-term care communities in NJ, FL, PA and CO. Juniper is dedicated to Nurturing the Spirit of Life in each individual served and believes the keys to healthy aging are an active body, an engaged mind, and a fulfilled spirit. The company`s mission is to serve its stakeholders, residents, families, employee associates, and investors with excellence and strong dedication to the company`s hallmarks of quality, value and innovation.

Innovasa Corporation

Innovasa Corporation is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acadia Pharmaceuticals

Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson`s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome. And in early-stage clinical research, we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim. Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication`s legitimacy. If in doubt, please contact talentacquisition@acadia-pharm.com to verify.